Engineering methylaspartate ammonia lyase for the asymmetric synthesis of unnatural amino acids

Nature Chemistry

Volumn 4, Issue 6, 2012, Pages 478-484

  Raj, Hans ^a   Szymański, Wiktor ^b,c   De Villiers, Jandré ^a   Rozeboom, Henriëtte J ^b   Veetil, Vinod Puthan ^a   Reis, Carlos R ^a   De Villiers, Marianne ^a   Dekker, Frank J ^a   De Wildeman, Stefaan ^d   Quax, Wim J ^a   Thunnissen, Andy Mark W H ^b   Feringa, Ben L ^c   Janssen, Dick B ^b   Poelarends, Gerrit J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d DSM Pharmaceutical Products   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMMONIA LYASE; METHYLASPARTATE AMMONIA LYASE; METHYLASPARTATE AMMONIA-LYASE;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME ACTIVE SITE; SITE DIRECTED MUTAGENESIS; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

AMINO ACIDS; AMMONIA-LYASES; CATALYSIS; CATALYTIC DOMAIN; CRYSTALLOGRAPHY, X-RAY; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED;

EID: 84862847925     PISSN: 17554330     EISSN: 17554349     Source Type: Journal    
DOI: 10.1038/nchem.1338     Document Type: Article

References (33)

1. Sonke, T., Kaptein, B. & Schoemaker, H. E. Use of enzymes in the synthesis of amino acids, in Amino Acids, Peptides and Proteins in Organic Chemistry Vol. 1 (ed. Hughes, A. B.) 77-117 (Wiley-VCH, 2009).
2. Wohlgemuth, R. Biocatalysis-key to sustainable industrial chemistry. Curr. Opin. Biotechnol. 21, 713-724 (2010).
3. Panke, S. & Wubbolts, M. Advances in biocatalytic synthesis of pharmaceutical intermediates. Curr. Opin. Chem. Biol. 9, 188-194 (2005).
4. Panke, S., Held, M. & Wubbolts, M. Trends and innovations in industrial biocatalysis for the production of fine chemicals. Curr. Opin. Biotechnol. 15, 272-279 (2004).
5. Turner, N. J. Ammonia lyases and aminomutases as biocatalysts for the synthesis of a-amino and β-amino acids. Curr. Opin. Chem. Biol. 15, 234-240 (2011).
6. Barker, H. A., Smyth, R. D.,Wilson, R. M. &Weissbach, H. The purification and properties of β-methylaspartase. J. Biol. Chem. 234, 320-328 (1959).
7. Goda, S. K., Minton, N. P., Botting, N. P. & Gani, D. Cloning, sequencing, and expression in Escherichia coli of the Clostridium tetanomorphum gene encoding β-methylaspartase and characterization of the recombinant protein. Biochemistry 31, 10747-10756 (1992).
8. Raj, H. et al. Alteration of the diastereoselectivity of 3-methylaspartate ammonia lyase by using structure-based mutagenesis. ChemBioChem 10, 2236-2245 (2009).
9. Bright, H. J. Divalent metal activation of β-methylaspartase. The importance of ionic radius. Biochemistry 6, 1191-1203 (1967).
10. Bright, H. J. On the mechanism of divalent metal activation of β-methylaspartase. J. Biol. Chem. 240, 1198-1210 (1965).
11. Kato, Y. & Asano, Y. 3-Methylaspartate ammonia-lyase as a marker enzyme of the mesaconate pathway for (S)-glutamate fermentation in Enterobacteriaceae. Arch. Microbiol. 168, 457-463 (1997).
12. Asuncion, M., Blankenfeldt, W., Barlow, J. N., Gani, D. & Naismith, J. H. The structure of 3-methylaspartase from Clostridium tetanomorphum functions via the common enolase chemical step. J. Biol. Chem. 277, 8306-8311 (2002).
13. Levy, C. W. et al. Insights into enzyme evolution revealed by the structure of methylaspartate ammonia lyase. Structure 10, 105-113 (2002).
14. Bright, H. J., Ingraham, L. L. & Lundin, R. E. The mechanism of the methylaspartate ammonia-lyase reaction: deuterium exchange. Biochim. Biophys. Acta 81, 576-584 (1964).
15. Bright, H. The mechanism of the β-methylaspartase reaction. J. Biol. Chem. 239, 2307-2315 (1964).
16. Babbitt, P. C. et al. The enolase superfamily: a general strategy for enzymecatalyzed abstraction of the a-protons of carboxylic acids. Biochemistry 35, 16489-16501 (1996).
17. Akhtar, M., Botting, N. P., Cohen, M. A. & Gani, D. Enantiospecific synthesis of 3-substituted aspartic acids via enzymic amination of substituted fumaric acids. Tetrahedron 43, 5899-5908 (1987).
18. Botting, N. P., Akhtar, M., Cohen, M. A. & Gani, D. Substrate specificity of the 3-methylaspartate ammonia-lyase reaction: observation of differential relative reaction rates for substrate-product pairs. Biochemistry 27, 2953-2955 (1988).
19. Gulzar, M. S., Akhtar, M. & Gani, D. Preparation of N-substituted aspartic acids via enantiospecific conjugate addition of N-nucleophiles to fumaric acids using methylaspartase: synthetic utility and mechanistic implications. J. Chem. Soc. Perkin Trans. 1, 649-656 (1997).
20. Lutz, S. & Bornscheuer, U. T. Protein Engineering Handbook. Vols 1-2 (Wiley-VCH, 2009).
21. Reetz, M. T., Bocola, M., Carballeira, J. D., Zha, D. & Vogel, A. Expanding the range of substrate acceptance of enzymes: combinatorial active-site saturation test. Angew. Chem. Int. Ed. 44, 4192-4196 (2005).
22. Morley, K. L. & Kazlauskas, R. J. Improving enzyme properties: when are closer mutations better? Trends Biotechnol. 23, 231-237 (2005).
23. Arnold, F. H. & Georgiou, G. (eds) Methods in Molecular Biology (Directed Enzyme Evolution) Vol. 230 (Humana Press, 2003).
24. Turner, N. J. Directed evolution drives the next generation of biocatalysts. Nature Chem. Biol. 5, 567-573 (2009).
25. Shimamoto, K. et al. Characterization of novel L-threo-b- benzyloxyaspartate derivatives, potent blockers of the glutamate transporters. Mol. Pharmacol. 65, 1008-1015 (2004).
26. Shimamoto, K. Glutamate transporter blockers for elucidation of the function of excitatory neurotransmission systems. Chem. Rec. 8, 182-199 (2008).
27. Esslinger, C. S. et al. The substituted aspartate analogue L-b-threo-benzylaspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3. Neuropharmacology 49, 850-861 (2005).
28. Bridges, R. J. & Esslinger, C. S. The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes. Pharmacol. Ther. 107, 271-285 (2005).
29. Mavencamp, T. L., Rhoderick, J. F., Bridges, R. J. & Esslinger, C. S. Synthesis and preliminary pharmacological evaluation of novel derivatives of L-b-threobenzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3. Bioorg. Med. Chem. 16, 7740-7748 (2008).
30. Shimamoto, K. et al. Syntheses of optically pure β-hydroxyaspartate derivatives as glutamate transporter blockers. Bioorg. Med. Chem. Lett. 10, 2407-2410 (2000).
31. Spengler, J., Pelay, M., Tulla-Puche, J. & Albericio, F. Synthesis of orthogonally protected L-threo-b-ethoxyasparagine. Amino Acids 39, 161-165 (2010).
32. LaBean, T. H. & Kauffman, S. A. Design of synthetic gene libraries encoding random sequence proteins with desired ensemble characteristics. Protein Sci. 2, 1249-1254 (1993).
33. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K. & Pease, L. R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59 (1989).